Fysioterapi Brønshøj ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  0.0% 0.0% 8.5% 1.8% 1.6%  
Credit score (0-100)  0 0 28 70 72  
Credit rating  N/A N/A BB A A  
Credit limit (kDKK)  0.0 0.0 -0.0 4.1 11.2  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 4,095 13,336 14,213  
EBITDA  0.0 0.0 -143 7,210 5,559  
EBIT  0.0 0.0 -976 6,245 4,594  
Pre-tax profit (PTP)  0.0 0.0 -1,331.5 5,451.3 3,722.3  
Net earnings  0.0 0.0 -1,331.5 4,544.3 2,899.2  
Pre-tax profit without non-rec. items  0.0 0.0 -1,331 5,451 3,722  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4

Tangible assets total  0.0 0.0 370 285 200  
Shareholders equity total  0.0 0.0 -1,291 3,253 3,052  
Interest-bearing liabilities  0.0 0.0 2,510 1,660 1,727  
Balance sheet total (assets)  0.0 0.0 19,417 24,027 23,170  

Net Debt  0.0 0.0 2,510 -1,326 1,644  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 4,095 13,336 14,213  
Gross profit growth  0.0% 0.0% 0.0% 225.7% 6.6%  
Employees  0 0 11 14 18  
Employee growth %  0.0% 0.0% 0.0% 27.3% 28.6%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 19,417 24,027 23,170  
Balance sheet change%  0.0% 0.0% 0.0% 23.7% -3.6%  
Added value  0.0 0.0 -143.0 7,077.4 5,558.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 16,359 -1,930 -1,930  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 1.0 2.0  

Profitability 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% -23.8% 46.8% 32.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -4.7% 28.4% 20.2%  
ROI %  0.0% 0.0% -38.6% 155.2% 82.4%  
ROE %  0.0% 0.0% -6.9% 40.1% 92.0%  

Solidity 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  0.0% 0.0% -6.2% 13.5% 13.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -1,755.0% -18.4% 29.6%  
Gearing %  0.0% 0.0% -194.3% 51.0% 56.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 28.7% 43.1% 61.4%  

Liquidity 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  0.0 0.0 1.3 6.2 2.6  
Current Ratio  0.0 0.0 1.3 6.2 2.6  
Cash and cash equivalent  0.0 0.0 0.0 2,986.0 83.5  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 497.4 6,520.7 4,896.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -13 506 309  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -13 515 309  
EBIT / employee  0 0 -89 446 255  
Net earnings / employee  0 0 -121 325 161